MedTrace Logo

A Long-term Follow-up Study of Patients Who Received MB-105

NCT07340814 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-01-14

No results posted yet for this study

Summary

This study is to fulfil the regulatory requirement for 15-year follow-up for patients treated with MB-105 in any study

Conditions

  • Any Patient Treated With MB-105

Interventions

BIOLOGICAL

MB-105

This is an observational study with no study product administered because it is the LTFU study for patients who received the product in another study

Sponsors & Collaborators

  • March Biosciences Inc

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-27
Primary Completion
2040-10-15
Completion
2040-10-15
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07340814 on ClinicalTrials.gov